238 related articles for article (PubMed ID: 28527686)
1. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S
Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686
[TBL] [Abstract][Full Text] [Related]
2. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
[TBL] [Abstract][Full Text] [Related]
3. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
5. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
6. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus.
Cai D; Song Q; Duan C; Wang S; Wang J; Zhu Y
Vaccine; 2018 Sep; 36(37):5591-5599. PubMed ID: 30077483
[TBL] [Abstract][Full Text] [Related]
8. Recombinant E
Wang S; Yang G; Nie J; Yang R; Du M; Su J; Wang J; Wang J; Zhu Y
Vaccine; 2020 May; 38(22):3881-3891. PubMed ID: 32280039
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
[TBL] [Abstract][Full Text] [Related]
10. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
11. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
[TBL] [Abstract][Full Text] [Related]
12. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
[TBL] [Abstract][Full Text] [Related]
15. Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination.
Endsley JJ; Quade MJ; Terhaar B; Roth JA
Vet Ther; 2002; 3(4):364-72. PubMed ID: 12584672
[TBL] [Abstract][Full Text] [Related]
16. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle.
Liang R; van den Hurk JV; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2006 Oct; 87(Pt 10):2971-2982. PubMed ID: 16963756
[TBL] [Abstract][Full Text] [Related]
17. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
18. Maternal antibody blocks humoral but not T cell responses to BVDV.
Endsley JJ; Roth JA; Ridpath J; Neill J
Biologicals; 2003 Jun; 31(2):123-5. PubMed ID: 12770543
[TBL] [Abstract][Full Text] [Related]
19. A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic Escherichia coli and homologous bovine viral diarrhea virus in vitro.
Hashish EA; Zhang C; Ruan X; Knudsen DE; Chase CC; Isaacson RE; Zhou G; Zhang W
Clin Vaccine Immunol; 2013 Jul; 20(7):1076-83. PubMed ID: 23697572
[TBL] [Abstract][Full Text] [Related]
20. Immunization with recombinant E
Wang SH; Yang GH; Nie JW; Wang J; Wang YX; Du MZ; Guo L; Yang RJ; Zhu YH
Vet Microbiol; 2021 Aug; 259():109084. PubMed ID: 34153721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
